ScholarIQanswers from OpenAlex & ORCID
Andreas Hochhaus
ResearcherPublications, citations & collaboration network
Andreas Hochhaus is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Andreas Hochhaus have?
ScholarIQindexed works
Andreas Hochhaus has 1,652 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Andreas Hochhaus have?
ScholarIQcitation count
Andreas Hochhaus has 91,757 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Andreas Hochhaus?
ScholarIQh-index
Andreas Hochhaus has an h-index of 129 in OpenAlex.
What is the i10-index of Andreas Hochhaus?
ScholarIQi10-index
Andreas Hochhaus has an i10-index of 687 in OpenAlex.
What is the ORCID of Andreas Hochhaus?
ScholarIQorcid
The ORCID for Andreas Hochhaus is on the source record.
What is the OpenAlex record for Andreas Hochhaus?
ScholarIQopenalex
The OpenAlex for Andreas Hochhaus is on the source record.
What are the most-cited papers on Andreas Hochhaus?
ScholarIQmost cited works
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Andreas Hochhaus, Michele Baccarani, Richard T. Silver, CA Schiffer, Jane F. Apperley, Francisco Cervantes, R E Clark, J. E. Cortes, Michael W. Deininger, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, J. Janssen, Hagop M. Kantarjian, D. W. Kim, Richard A. Larson, J. H. Lipton, F.-X. Mahon, Jiří Mayer, Franck E. Nicolini, D Niederwieser, Fabrizio Pane, Jerald P. Radich, Delphine Réa, Johan Richter, G Rosti, Philipe Rousselot, Giuseppe Saglio, Susanne Saußele, Simona Soverini, J. L. Steegmann, Anna Turkina, Andrey Zaritskey, R. Hehlmann
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
Susanne Saußele, Johan Richter, Joëlle Guilhot, Franz Gruber, Henrik Hjorth-Hansen, António Almeida, Jeroen J. W. M. Janssen, Jiřı́ Mayer, Perttu Koskenvesa, Panayiotis Panayiotidis, Ulla Olsson‐Strömberg, Joaquín Martínez‐López, Philippe Rousselot, Hanne Vestergaard, Hans Ehrencrona, Veli Kairisto, Kateřina Machová Poláková, Martin C. Müller, Satu Mustjoki, Marc Berger, Alice Fabarius, Wolf‐Karsten Hofmann, Andreas Hochhaus, Markus Pfirrmann, François‐Xavier Mahon, Gert J. Ossenkoppele, Maria Pagoni, Stina Söderlund, Martine Escoffre‐Barbe, Gabriel Étienne, Jolanta Dengler, Françoise Huguet, Nikolas von Bubnoff, Hana Klamová, Edgar Faber, François Guilhot, Kourosh Lotfi, Delphine Réa, Tim H. Brümmendorf, G.E. de Greef, Leif Stenke, Franck E. Nicolini, Laurence Legros, Andreas Burchert, J Voglová, Aude Charbonnier, Emmanuel Gyan, Volker Kunzmann, Peter E. Westerweel
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
Ralf‐Dieter Hofheinz, Frederik Wenz, Stefan Post, Axel Matzdorff, Stephan Laechelt, Jörg T. Hartmann, Lothar Müller, Hartmut Link, Markus Moehler, E. Kettner, Elisabeth Fritz, U. Hieber, Hans Walter Lindemann, Martina Grunewald, Stephan Kremers, Christian Constantin, Matthias Hipp, G. Hartung, Deniz Gencer, Peter Kienle, Iris Burkholder, Andreas Hochhaus
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Andreas Hochhaus, Susanne Saußele, Gianantonio Rosti, F-X Mahon, J. Janssen, Henrik Hjorth‐Hansen, Johan Richter, Christian Buske